Clinical Trial

Evaluation of the Prognostic Value of Immature Platelet Fraction

Study acronym: IPSIS
Completed
View on ClinicalTrials.gov →
Summary
Sepsis is a public health issue responsible for six million deaths worldwide each year. It is one of the leading causes of admission and morbidity and mortality in critical care. Its most severe form, septic shock, is responsible for a picture of multiple organ failure syndrome with a high mortality rate estimated at 38%. It appears important to identify routinely available and low-cost biomarkers to identify patients at risk of adverse outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Status change: Active, Not Recruiting → Completed 2026-02-11
Trial Details
NCT Number NCT07039227
Lead Sponsor University Hospital, Rouen
Conditions Septic Shock
Enrollment 196 participants
Start Date 2023-04-28
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-13